Literature DB >> 10515426

Cystic fibrosis: inflammatory response to infection with Burkholderia cepacia and Pseudomonas aeruginosa.

J Hendry1, J S Elborn, L Nixon, D J Shale, A K Webb.   

Abstract

Pulmonary colonization by Burkholderia cepacia in cystic fibrosis (CF) may be associated with enhanced deterioration of pulmonary function. This may be due to a more florid host inflammatory response than in colonization by Pseudomonas aeruginosa, leading to greater lung injury. Circulating markers of inflammation were determined during infective exacerbations and periods of clinical stability in an 18 month prospective study in adults with CF colonized by P. aeruginosa (n=41). B. cepacia (n=13) and in adults who intermittently grew B. cepacia (n=6). There were no differences between the levels of the inflammation markers measured in the three groups (P. aeruginosa, B. cepacia, B. cepacia intermittent) at any of the assessment points. When clinically stable, levels of inflammatory markers in all groups were elevated compared to a matched non-CF population, indicating, continuous inflammation and the potential for lung damage between infective exacerbations. This study does not support the hypothesis that pulmonary colonization with Burkholderia cepacia is associated with a heightened inflammatory response compared with Pseudomonas aeruginosa colonization.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10515426     DOI: 10.1034/j.1399-3003.1999.14b32.x

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  11 in total

1.  Autophagy stimulation by rapamycin suppresses lung inflammation and infection by Burkholderia cenocepacia in a model of cystic fibrosis.

Authors:  Basant A Abdulrahman; Arwa Abu Khweek; Anwari Akhter; Kyle Caution; Sheetal Kotrange; Dalia H A Abdelaziz; Christie Newland; Roberto Rosales-Reyes; Benjamin Kopp; Karen McCoy; Richard Montione; Larry S Schlesinger; Mikhail A Gavrilin; Mark D Wewers; Miguel A Valvano; Amal O Amer
Journal:  Autophagy       Date:  2011-11-01       Impact factor: 16.016

Review 2.  The role of inflammation in the pathophysiology of CF lung disease.

Authors:  James F Chmiel; Melvin Berger; Michael W Konstan
Journal:  Clin Rev Allergy Immunol       Date:  2002-08       Impact factor: 8.667

3.  Neutrophil cell death, activation and bacterial infection in cystic fibrosis.

Authors:  A P Watt; J Courtney; J Moore; M Ennis; J S Elborn
Journal:  Thorax       Date:  2005-08       Impact factor: 9.139

4.  Potential of anti-inflammatory treatment for cystic fibrosis lung disease.

Authors:  Jennifer L Taylor-Cousar; Kelsey A Von Kessel; Robert Young; David P Nichols
Journal:  J Inflamm Res       Date:  2010-08-10

5.  Organisms isolated from adults with cystic fibrosis.

Authors:  Terence E McManus; Andrew McDowell; John E Moore; Stuart J Elborn
Journal:  Ann Clin Microbiol Antimicrob       Date:  2004-12-15       Impact factor: 3.944

6.  Clinical utility of C-reactive protein to predict treatment response during cystic fibrosis pulmonary exacerbations.

Authors:  Ashutosh Sharma; Gordon Kirkpatrick; Virginia Chen; Kate Skolnik; Zsuzsanna Hollander; Pearce Wilcox; Bradley S Quon
Journal:  PLoS One       Date:  2017-02-08       Impact factor: 3.240

7.  Divergence of bacterial communities in the lower airways of CF patients in early childhood.

Authors:  John B O'Connor; Madison M Mottlowitz; Brandie D Wagner; Kathleen L Boyne; Mark J Stevens; Charles E Robertson; Jonathan K Harris; Theresa A Laguna
Journal:  PLoS One       Date:  2021-10-06       Impact factor: 3.752

Review 8.  State of the art: why do the lungs of patients with cystic fibrosis become infected and why can't they clear the infection?

Authors:  James F Chmiel; Pamela B Davis
Journal:  Respir Res       Date:  2003-08-27

9.  Plasma sCD14 as a biomarker to predict pulmonary exacerbations in cystic fibrosis.

Authors:  Bradley S Quon; David A Ngan; Pearce G Wilcox; S F Paul Man; Don D Sin
Journal:  PLoS One       Date:  2014-02-20       Impact factor: 3.240

10.  Role of C-reactive protein as a biomarker for prediction of the severity of pulmonary exacerbations in patients with cystic fibrosis.

Authors:  Rosa Maria Girón-Moreno; José L Justicia; Sara Yamamoto; Claudia Valenzuela; Carolina Cisneros; Rosa Mar Gómez-Punter; Gilda Fernandes-Vasconcelos; Julio Ancochea
Journal:  BMC Pulm Med       Date:  2014-09-23       Impact factor: 3.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.